Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma

HIGHLIGHTS

• who: Huarong Zhang from the The study was approved by Ethics Review from Branch from Research and Clinical Technology Application, Ethics Committee of First Affiliated Hospital of Fujian Medical University (Approval NoMRCTA, ECFAH of FMU [2017]019) and performed according to the Helsinki Declaration. All participant signed informed consent before enrolment. Patients who were diagnosed as chronic HBV liver disease with positive HBV surface antigen test for at least , months were recruited from the liver disease center of the first affiliated hospital of Fujian medical university. All participants were excluded from liver diseases caused by other viruses . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.